Erasca (ERAS) Accounts Payables (2020 - 2026)
Erasca (ERAS) posted Accounts Payables of $2.2 million for Q1 2026, up 120.49% on a QoQ basis from $981000.0 in Q4 2025, and down 4.38% year-over-year from $2.3 million in Q1 2025.
Erasca (ERAS) Accounts Payables (2020 - 2026) Analysis & Trends
Erasca's Accounts Payables history runs 7 years deep, the most recent figure standing at $2.2 million for Q1 2026.
- Quarterly Accounts Payables fell 4.38% year-over-year to $2.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.2 million (down 4.38% YoY) and the FY2025 annual result came in at $981000.0, up 109.62% from the prior year.
- Accounts Payables was $2.2 million for Q1 2026 at Erasca, up from $981000.0 in the prior quarter.
- Across five years, Accounts Payables topped out at $23.0 million in Q4 2022 and bottomed at $468000.0 in Q4 2024.
- A 5-year average of $3.8 million and a median of $2.4 million in 2024 frame the typical range for Accounts Payables.
- Annual changes were most pronounced in 2022 — Accounts Payables soared 392.82% — and 2023, when it sank 91.32%.
- Erasca's Accounts Payables stood at $23.0 million in 2022, then sank by 91.32% to $2.0 million in 2023, then tumbled by 76.6% to $468000.0 in 2024, then surged by 109.62% to $981000.0 in 2025, then soared by 120.49% to $2.2 million in 2026.
- Business Quant data shows ERAS's Accounts Payables at $2.2 million in Q1 2026, $981000.0 in Q4 2025, and $3.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 5.74 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 10.62 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 423.55 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 694,346.76 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 489.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.03 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.52 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 80.54 Mn |
| 10 | Erasca | 5.89 Bn | 5.89 Bn | - | 2.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.16 Mn |
| Dec 31, 2025 | 981,000.00 |
| Sep 30, 2025 | 3.03 Mn |
| Jun 30, 2025 | 1.66 Mn |
| Mar 31, 2025 | 2.26 Mn |
| Dec 31, 2024 | 468,000.00 |
| Sep 30, 2024 | 2.41 Mn |
| Jun 30, 2024 | 2.14 Mn |
| Mar 31, 2024 | 2.63 Mn |
| Dec 31, 2023 | 2.00 Mn |
| Sep 30, 2023 | 3.70 Mn |
| Jun 30, 2023 | 2.63 Mn |
| Mar 31, 2023 | 3.35 Mn |
| Dec 31, 2022 | 23.05 Mn |
| Sep 30, 2022 | 4.32 Mn |
| Jun 30, 2022 | 2.29 Mn |
| Mar 31, 2022 | 4.71 Mn |
| Dec 31, 2021 | 4.68 Mn |
| Sep 30, 2021 | 1.32 Mn |
| Jun 30, 2021 | 1.51 Mn |